The abnormal expression or activity disturbance of the FOXO1 transcription factor is related to multiple gynecological diseases, such as endometrial cancer, endometriosis, and ovarian dysfunction, which in turn highlights its potential as a therapeutic target [22,23]. This evidence concerns the gene FOXO1 and ovarian dysfunction.